| Mark Walter Deroo, MD | |
|
23450 College Blvd, Olathe, KS 66061-8702 | |
| (913) 764-7788 | |
| (913) 764-6088 |
| Full Name | Mark Walter Deroo |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 23450 College Blvd, Olathe, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982657516 | NPI | - | NPPES |
| 100293370E | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0427012 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Walter Deroo, MD 23450 College Blvd, Olathe, KS 66061-8702 Ph: (913) 764-7788 | Mark Walter Deroo, MD 23450 College Blvd, Olathe, KS 66061-8702 Ph: (913) 764-7788 |
News Archive
New research found that moderate exercise does not improve lipoprotein concentrations in obese patients with non alcoholic fatty liver disease (NAFLD). Results published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, report that moderate physical activity produces only a small decrease in triglyceride and alanine transaminase (ALT) levels.
Despite the use of personal protective equipment, reports show that many health care workers contracted the coronavirus disease, which raises substantial concerns about the effectiveness of the PPE.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Aspect Magnet Technologies and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a Memorandum of Understanding (MoU) for the development of a high performance desktop preclinical MRI system.
HemaCare Corporation announced today profitable second quarter 2010 results with a 4% increase in revenue over the first quarter of the year, and $224,000 of net income, a significant improvement over the first quarter loss of $204,000. The first quarter loss included $184,000 in severance payments to the Company's former Chief Executive Officer and Chief Financial Officer.
› Verified 8 days ago
Pamela A Mckean, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20930 W 151st St, Olathe, KS 66061 Phone: 913-782-2525 Fax: 913-782-9307 | |
Dr. Tara Jill Grimaldi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 20930 W 151st, Olathe, KS 66061 Phone: 913-782-2525 Fax: 913-782-9307 | |
Carlos Manuel Monzon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20930 W 151st St, Olathe, KS 66061 Phone: 913-782-2525 Fax: 913-782-9307 | |
Dr. Chet Daniel Johnson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 23450 College Blvd, Olathe, KS 66061 Phone: 913-764-7788 Fax: 913-764-6088 | |
Dr. Heather M Baker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 20930 W 151st St, Olathe, KS 66061 Phone: 913-782-2525 Fax: 913-782-9307 | |
Dr. O. Keith Enlow, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 824 W Frontier Ln, Olathe, KS 66061 Phone: 913-764-7060 Fax: 913-764-8059 | |
Dr. Samah Ribhi Murad, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 17516 W 158th St, Olathe, KS 66062 Phone: 913-768-0422 |